Factor V Leiden: symptoms, treatment, and when to worry
Last updated September 3, 2026.
Factor V Leiden is a common inherited gene change that makes blood slightly more prone to clotting, raising the risk of deep vein thrombosis (DVT) and pulmonary embolism. A few percent of people with European ancestry carry it, most never know, and most carriers never clot. It matters most when combined with other risks: surgery, hormones, pregnancy, immobility.
What does it mean to carry it?
The gene change makes activated factor V resist being switched off, so clotting runs a little hotter. Heterozygotes, one copy, carry a modestly raised clot risk; homozygotes, two copies, carry a substantially higher one. The condition itself has no symptoms: it is found after a DVT, after several miscarriages in some workups, or through family testing. Crucially, the everyday risk is low; the risk concentrates around trigger situations like major surgery, long flights, estrogen contraception, and pregnancy.
What actually helps?
- Testing is selective: usually offered after an unexplained or young-age DVT, recurrent clots, or strong family history, rather than as general screening.
- No standing treatment for most carriers: people with Factor V Leiden who have never clotted generally need no blood thinners, just risk awareness.
- Manage the triggers: blood-thinner cover around surgery and prolonged immobility, good hydration and movement on long trips, and compression stockings when advised.
- Make hormone decisions with it in mind: estrogen-containing contraception and hormone therapy raise clot risk further, so carriers discuss alternatives with their clinician rather than simply starting them.
- Pregnancy planning: carriers with a clotting history get individualized plans, sometimes including preventive blood thinners during pregnancy and after delivery.
- After a clot: a DVT in a carrier is treated normally, and the duration of blood thinners is individualized by the circumstances.
When is it an emergency?
The emergency is the clot, not the gene. Same-day urgent care for a swollen, painful, warm calf or thigh. Call 911 for sudden breathlessness, chest pain that is sharp or worse on breathing, coughing blood, faintness, or a racing heart, which suggest a clot in the lungs. Anyone with Factor V Leiden should treat those symptoms as urgent even when feeling otherwise well. Pymander's escalation routing is built and tested specifically for this class of decision; see the safety architecture working paper.
What a Pymander AI doctor consult looks like
Illustrative example, not a real member's messages.
Common questions
If I have Factor V Leiden, will I definitely get a blood clot?
No. Most carriers never clot. One copy raises the lifetime DVT risk modestly, two copies more substantially, but the baseline absolute risk stays low, and the danger concentrates around triggers: surgery, immobility, estrogen hormones, pregnancy, cancer, long flights. The gene is best understood as a multiplier of other risks rather than a destiny, which is why management is about situations, not daily medication.
Should my family members be tested for Factor V Leiden?
Sometimes. Testing first-degree relatives is considered when the result would change management, for example a sister weighing estrogen contraception, or family members with their own clotting history. It is not routine for everyone, because a positive result in someone who will never face the triggers changes little. A hematology or GP conversation maps who in the family actually benefits from knowing.
Can I take the pill if I have Factor V Leiden?
Estrogen-containing contraception raises clot risk several-fold on its own, and Factor V Leiden multiplies that further, so the combined pill is generally discouraged in known carriers, especially after a personal or strong family clot history. The alternatives work well: progestin-only pills, implants, injections, and intrauterine devices do not carry the same clot risk. This is a decision made with the clinician, with the carrier status on the table.
What happens if a carrier gets pregnant?
Pregnancy itself raises clot risk, so carriers get individualized plans. Those with only one gene copy and no clotting history often need no treatment, just vigilance and post-delivery precautions. Carriers with a personal or strong family history, or two copies, may get preventive blood-thinner injections during pregnancy and for the weeks after delivery, when risk peaks. An early conversation with the maternity team sets the plan.
Is Factor V Leiden the same as hemophilia?
Opposite directions of the same system. Hemophilia is too little clotting, causing bleeding; Factor V Leiden is clotting that switches off too slowly, causing clots. They share nothing clinically beyond the word clotting. A person with Factor V Leiden does not bleed more, and a person with hemophilia does not clot more. The names confuse people precisely because both involve clotting factors.
What is the treatment after a DVT in someone with Factor V Leiden?
The clot itself is treated the same as anyone's: blood thinners for at least three months. The carrier status then informs the duration decision: a DVT provoked by surgery may end treatment on schedule, while unprovoked or recurrent clots, especially with two gene copies, tilt toward longer or indefinite anticoagulation. That decision weighs bleeding risk against clot risk individually, and it is revisited rather than set in stone.